Efficacy of Immune Checkpoint Inhibitors and Their Combinations in Previously Treated Advanced Hepatocellular Carcinoma: A Systematic Review of Clinical Trials

被引：0
|
作者：
Aiman, Wajeeha [1 ]
Ali, Muhammad Ashar [2 ]
Ali, Mukarram Jamat [3 ]
Rayad, Mohammad Nabil [1 ]
Mirza, Noreen [1 ]
Shaaban, Hamid [1 ]
Guron, Gunwant [1 ]
Maroules, Michael [2 ]
机构：
[1] St Michaels Hosp, Newark, NJ USA
[2] St Marys & St Clares Hosp, New York Med Coll, Denville, NJ USA
[3] Howard Univ Hosp, Washington, DC USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1619
引用
收藏
页码：S1215 / S1216
页数：2
相关论文
共 50 条
  • [21] The safety and efficacy of lenvatinib combined with immune checkpoint inhibitors therapy for advanced hepatocellular carcinoma
    Wang, Yun
    Jiang, Man
    Zhu, Jingjuan
    Qu, Jialin
    Qin, Kang
    Zhao, Deze
    Wang, Li
    Dong, Lina
    Zhang, Xiaochun
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2020, 132
  • [22] The Impact of Proton Pump Inhibitors on the Efficacy of Immune Checkpoint Inhibitor Combinations in Patients with HBV-Associated Advanced Hepatocellular Carcinoma
    Wang, Ningning
    Xu, Yuanyuan
    Yang, Guangde
    Chen, He
    Wang, Xia
    Fu, Juanjuan
    Li, Li
    Pan, Xiucheng
    [J]. JOURNAL OF HEPATOCELLULAR CARCINOMA, 2024, 11 : 1311 - 1321
  • [23] Efficacy and Safety of Amrubicin in Small Cell Carcinoma Previously Treated with Immune Checkpoint Inhibitors and Chemotherapy
    Nishimura, Tadashi
    Fujimoto, Hajime
    Fujiwara, Takumi
    Ito, Kentaro
    Fujiwara, Atsushi
    Yuda, Hisamichi
    Itani, Hidetoshi
    Naito, Masahiro
    Kodama, Shuji
    Yagi, Akihiko
    D'Alessandro, Valeria Fridman
    Yasuma, Taro
    Furuhashi, Kazuki
    Saiki, Haruko
    Okano, Tomohito
    Tomaru, Atsushi
    Tanigawa, Motoaki
    D'Alessandro-Gabazza, Corina N.
    Gabazza, Esteban C.
    Yoshida, Masamichi
    Hataji, Osamu
    Ibata, Hidenori
    Kobayashi, Tetsu
    [J]. CANCERS, 2022, 14 (16)
  • [24] Efficacy and safety of transarterial chemoembolization combining sorafenib with or without immune checkpoint inhibitors in previously treated patients with advanced hepatocellular carcinoma: A propensity score matching analysis
    Yang, Xue-Gang
    Sun, Yan-Yuan
    Wang, Hai-Qing
    Li, De-Shan
    Xu, Guo-Hui
    Huang, Xiao-Qi
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [25] Progress of immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma
    Liu, Tong
    Meng, Guorui
    Ma, Shihui
    You, Junqi
    Yu, Liang
    He, Risheng
    Zhao, Xudong
    Cui, Yunfu
    [J]. FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [26] Biomarkers predicting the efficacy of immune checkpoint inhibitors in hepatocellular carcinoma
    Qin, Ran
    Jin, Tianqiang
    Xu, Feng
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [27] EFFICACY AND TOLERABILITY OF IMMUNE CHECKPOINT INHIBITORS FOR ADVANCED HEPATOCELLULAR CARCINOMA WITH CHILD- PUGH CLASS B: A SYSTEMATIC REVIEW AND META- ANALYSIS
    Xie, Enrui
    Yeo, Yee Hui
    Scheiner, Bernhard
    Zhang, Yue
    Hiraoka, Atsushi
    Tantai, Xinxing
    Fessas, Petros
    De Castro, Tiago
    D'Alessio, Antonio
    Xu, Shuo
    Fulgenzi, Claudia Angela Maria
    Tsai, Hong-Ming
    Kambhampati, Swetha
    Wang, Wenjun
    Gao, Xu
    Xing, Zixuan
    Pinter, Matthias
    Lin, Yih-Jyh
    Guo, Zhanjun
    Vogel, Arndt
    Tanaka, Takaaki
    Kuo, Hsin-Yu
    Kelley, Kate
    Kudo, Masatoshi
    Yang, Ju Dong
    Pinato, David James
    Ji, Fanpu
    [J]. HEPATOLOGY, 2023, 78 : S1836 - S1837
  • [28] Surrogate end points for survival in patients with advanced hepatocellular carcinoma treated with immune checkpoint inhibitors
    Zhu, Andrew X.
    Lin, Yong
    Ferry, David
    Widau, Ryan C.
    Saha, Abhijoy
    [J]. IMMUNOTHERAPY, 2022, 14 (16) : 1341 - 1351
  • [29] Outcomes in advanced hepatocellular carcinoma (HCC) patients (pts) treated with immune checkpoint inhibitors (ICI)
    Cowzer, D.
    Capanu, M.
    Keane, F.
    Khalil, D.
    Shia, J.
    Do, R.
    Chou, J.
    Walch, H.
    El Dika, I.
    Yaqubie, A.
    Solit, D.
    Berger, M.
    O'Reilly, E.
    Harding, J.
    Abou-Alfa, G.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S109 - S109
  • [30] Neoadjuvant Immune Checkpoint Inhibitors in hepatocellular carcinoma: a meta-analysis and systematic review
    Tian, Chunhong
    Yu, Yifan
    Wang, Yuqing
    Yang, Lunwei
    Tang, Ying
    Yu, Chengyang
    Feng, Gaofei
    Zheng, Dayong
    Wang, Xiongwen
    [J]. FRONTIERS IN IMMUNOLOGY, 2024, 15
12345